Navigation Links
ADVENTRX Announces Results From ANX-514 Bioequivalence Study
Date:5/7/2009

study drugs, had no major violations of the inclusion/exclusion criteria and had complete pharmacokinetic data were included in the analysis.

About ANX-514 (docetaxel emulsion)

ANX-514 is a novel nano-emulsion formulation of the chemotherapy drug docetaxel, a formulation of which is marketed under the brand name Taxotere. ANX-514 is formulated without polysorbate 80 or other detergents and is intended to reduce the severity and/or incidence of hypersensitivity reactions. Docetaxel is an anti-cancer agent that acts by disrupting the cellular microtubular network that is essential for cell division. Immunosuppressant premedication is recommended for docetaxel therapy to reduce the incidence and severity of hypersensitivity reactions. Docetaxel is approved to treat breast, non-small cell lung, prostate, gastric and head and neck cancers.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a biopharmaceutical company whose proprietary product candidates are designed to improve the safety and commercial potential of existing cancer treatments. In December 2008, the Company announced that it is exploring a range of strategic options, including the sale or disposition of one or more of its product candidate programs, a strategic business merger and other transactions that maximize the value of the Company's assets. In January and March 2009, the Company announced headcount reductions and cost containment measures to provide additional time to consummate a strategic transaction or otherwise obtain financing. More information can be found on the Company's web site at www.adventrx.com.

Forward Looking Statements

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks and assumptions that, if they ma
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
2. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
3. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
4. ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
5. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
6. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
7. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
8. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
9. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
10. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Doctors from the Sheikh Zayed Institute for Pediatric ... are the first in the United ... but painful bone tumor that commonly occurs in children ... focused ultrasound (MR-HIFU) method. Two patients, 16-year-old Alfredo ... been treated successfully in a research study aimed at ...
(Date:5/27/2015)... Water Street Healthcare Partners , ... care industry, announced today that it has formed ... world,s leading global health care companies. The partnership expands ... established in 2013 as a new way to ... pharmaceutical products and medical devices. Water ...
(Date:5/27/2015)... , May 25, 2015 Research ... announced the addition of the "2015 Strategies ... to their offering. This comprehensive five-country ... designed to help current suppliers and potential market ... the European coagulation testing market during the next ...
Breaking Medicine Technology:Children's National first in US to destroy bone tumors with incisionless surgery 2Children's National first in US to destroy bone tumors with incisionless surgery 3Children's National first in US to destroy bone tumors with incisionless surgery 4Water Street Announces Pharmaceutical Development Partnership with Global Health Care Company 2European Coagulation Testing Market Strategies 2015 2
... 14, 2011 Reportlinker.com announces that a new ... Bone Metastases Therapeutics - Pipeline ... http://www.reportlinker.com/p0479826/Bone-Metastases-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2017.html Bone Metastases ... 2017 Summary ...
... NEW YORK, April 14, 2011 Reportlinker.com ... is available in its catalogue: ... Generic Substitution Coupled With a Weak Pipeline ... http://www.reportlinker.com/p0481589/Sleep-Disorders-Market-to-2017---Generic-Substitution-Coupled-With-a-Weak-Pipeline-Will-Negatively-Impact-the-Market.html ...
Cached Medicine Technology:Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 4Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 5Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 6Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 7Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 8Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 9Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 2Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 3Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 4Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 5Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 6Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 7Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 8Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 9Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 10Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 11Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 12Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 13Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 14Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 15Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 16
(Date:5/27/2015)... (PRWEB) May 27, 2015 “ Nursing Homes ... care ,” reads the title of a recent April 2015 ... take elderly loved ones to the hospital, 20-plus years of ... This research shows that high-quality nursing homes are both safer ... With the quality of nursing homes varying widely, patients and ...
(Date:5/27/2015)... While hair transplantation has been used successfully ... study conducted by a physician member of the International ... follicle grafting can help treat patients with non-healing chronic ... ISHRS, which offers research grants for the purpose of ... In the past decade, numerous scientific studies have corroborated ...
(Date:5/27/2015)... The new http://www.carsonenergy.com includes ... should consider oil and gas investing, the substantial tax ... drilled, industry news, IRA investing, definitions and acronyms, info-graphics ... knowledge and experience is now in one central location, ... able to access 24 hours a day, 7 days ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 CURE® ... (BCAN) , whose mission is to advance research, provide ... have joined forces to battle the fifth most common ... the bladder’s lining start to grow out of control. ... their families at every stage of the cancer experience ...
(Date:5/27/2015)... Difass USA, a modern supplement brand committed ... first three flagship products, Dormiva™, Relaxiva™ and Reminiva™. All ... http://www.difassusa.com . , A restful night’s sleep is ... people struggle with getting the full amount of sleep ... designed to help you fall asleep and stay asleep, ...
Breaking Medicine News(10 mins):Health News:BestNursingHomes.com Launches on National Senior Health and Fitness Day 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 3Health News:Carson Energy Launches Next Generation Investor Website 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 3Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2
... HealthDay Reporter , FRIDAY, April 27 (HealthDay News) -- Although ... to carry inhalers at school and 48 states have laws ... say that some kids are still being denied access ... school district handles this a little bit different, and for ...
... , FRIDAY, April 27 (HealthDay News) -- Given the ... shows that children prefer a living creature. Even babies ... animals, including those that may frighten many adults, such as ... Rutgers University found. The researchers conducted three separate experiments ...
... who are bullied are three times more likely than others to ... a new study. A team of researchers from the ... April 27 in the BMJ , could help identify those ... of self-harming behaviors included cutting and biting arms, pulling out clumps ...
... 26, 2012 - The mitotic spindle, an apparatus that ... than the standard textbook picture suggests, according to researchers ... (SEAS). The findings, which result from quantitative measurements ... journal Cell . The researchers used a ...
... Rochester Medical Center are testing whether different doses of an ... a standard dose in people with mild hypertension, possibly with ... launched clinical trial, funded with a $1.9 million grant from ... of its kind in the United States. The ...
... HealthDay Reporter , THURSDAY, April 26 (HealthDay News) -- ... help keep your brain functioning well as you age, new ... the highest intake of berries appeared to delay cognitive aging ... such as thinking, remembering and reasoning. "Given that ...
Cached Medicine News:Health News:Some Schools Don't Let Kids Carry Asthma Inhalers 2Health News:Some Schools Don't Let Kids Carry Asthma Inhalers 3Health News:Bullied Children at Greater Risk for Self-Harm, Study Finds 2Health News:Slicing mitotic spindle with lasers, nanosurgeons unravel old pole-to-pole theory 2Health News:URMC clinical trial tests new regimen for hypertension 2Health News:Eating Berries Might Help Preserve Your Memory 2Health News:Eating Berries Might Help Preserve Your Memory 3
... macular health. Snellen charts available ... Easy to mount on most ... in a few minutes. Rapid ... Retinal vision testing without refraction ...
Eye Q Lite is ideal for color and red-free imaging used in general clinical and optometric casework such as anterior segmenting and diabetic screening....
The Genesis Camera meets the needs of those with specific requirements that cannot be met by a conventional 'chinrest' type camera....
The quick access to diabetic screening, panoramic images of the retina including peripheral area are available by using easy, semi automatic guidance of peripheral fixation....
Medicine Products: